Evaluation of Nod-like receptor (NLR) effector domain interactions

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Wagner, Roland N ^a   Proell, Martina ^a   Kufer, Thomas A ^b   Schwarzenbacher, Robert ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CASPASE RECRUITMENT DOMAIN PROTEIN 8; CRYOPYRIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR 12; PROTEIN ASC; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; UNCLASSIFIED DRUG; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN;

ARTICLE; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; BINDING SITE; CELL LINE; METABOLISM;

BINDING SITES; CELL LINE; HUMANS; NOD SIGNALING ADAPTOR PROTEINS; PROTEIN BINDING; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 64249098607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004931     Document Type: Article

References (66)

1. Dostert C, Meylan E, Tschopp J (2008) Intracellular pattern-recognition receptors. Adv Drug Deliv Rev 60: 830-840.
2. Carneiro LA, Magalhaes JG, Tattoli I, Philpott DJ, Travassos LH (2008) Nod-like proteins in inflammation and disease. J Pathol 214: 136-148.
3. Kufer TA (2008) Signal transduction pathways used by NLR-type innate immune receptors. Mol Biosyst 4: 380-386.
4. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, et al. (1999) Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 274: 14560-14567.
5. Faustin B, Reed JC (2008) Sunburned skin activates inflammasomes. Trends Cell Biol 18: 4-8.
6. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, et al. (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583-1589.
7. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, et al. (2008) The NLR gene family: a standard nomenclature. Immunity 28: 285-287.
8. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, et al. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300: 1584-1587.
9. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869-8872.
10. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126.
11. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856.
12. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
13. Proell M, Riedl SJ, Fritz JH, Rojas AM, Schwarzenbacher R (2008) The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS ONE 3: e2119.
14. Martinon F, Tschopp J (2005) NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26: 447-454.
15. Mariathasan S, Monack DM (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7: 31-40.
16. Yeretssian G, Labbe K, Saleh M (2008) Molecular regulation of inflammation and cell death. Cytokine.
17. Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, et al. (2000) An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem 275: 27823-27831.
18. Yoo NJ, Park WS, Kim SY, Reed JC, Son SG, et al. (2002) Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem Biophys Res Commun 299: 652-658.
19. Coussens NP, Mowers JC, McDonald C, Nunez G, Ramaswamy S (2007) Crystal structure of the Nod1 caspase activation and recruitment domain. Biochem Biophys Res Commun 353: 1-5.
20. Manon F, Favier A, Nunez G, Simorre JP, Cusack S (2007) Solution structure of NOD1 CARD and mutational analysis of its interaction with the CARD of downstream kinase RICK. J Mol Biol 365: 160-174.
21. Srimathi T, Robbins SL, Dubas RL, Hasegawa M, Inohara N, et al. (2008) Monomer/dimer transition of the caspase-recruitment domain of human Nod1. Biochemistry 47: 1319-1325.
22. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, et al. (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276: 4812-4818.
23. Rosenstiel P, Huse K, Till A, Hampe J, Hellmig S, et al. (2006) A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/ receptor-interacting protein kinase 2-induced signaling pathways. Proc Natl Acad Sci U S A 103: 3280-3285.
24. Masumoto J, Taniguchi S, Ayukawa K, Sarvotham H, Kishino T, et al. (1999) ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem 274: 33835-33838.
25. Masumoto J, Taniguchi S, Sagara J (2001) Pyrin N-terminal homology domain- and caspase recruitment domain-dependent oligomerization of ASC. Biochem Biophys Res Commun 280: 652-655.
26. Li H, Bergeron L, Cryns V, Pasternack MS, Zhu H, et al. (1997) Activation of caspase-2 in apoptosis. J Biol Chem 272: 21010-21017.
27. Pan Q, Mathison J, Fearns C, Kravchenko VV, Da Silva Correia J, et al. (2007) MDP-induced interleukin-1{beta} processing requires Nod2 and CIAS1/NALP3. J Leukoc Biol 82: 177-183.
28. Damiano JS, Oliveira V, Welsh K, Reed JC (2004) Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem J 381: 213-219.
29. Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, et al. (2008) A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci U S A 105: 7803-7808.
30. Geddes BJ, Wang L, Huang WJ, Lavellee M, Manji GA, et al. (2001) Human CARD12 is a novel CED4/Apaf-1 family member that induces apoptosis. Biochem Biophys Res Commun 284: 77-82.
31. Damiano JS, Stehlik C, Pio F, Godzik A, Reed JC (2001) CLAN, a novel human CED-4-like gene. Genomics 75: 77-83.
32. Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, et al. (2001) Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 276: 28309-28313.
33. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: 417-426.
34. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, et al. (2002) The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 277: 21119-21122.
35. Srimathi T, Robbins SL, Dubas RL, Chang H, Cheng H, et al. (2008) Mapping of POP1-binding site on pyrin domain of ASC. J Biol Chem 283: 15390-15398.
36. Stehlik C, Krajewska M, Welsh K, Krajewski S, Godzik A, et al. (2003) The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation. Biochem J 373: 101-113.
37. Pathan N, Marusawa H, Krajewska M, Matsuzawa S, Kim H, et al. (2001) TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. J Biol Chem 276: 32220-32229.
38. Razmara M, Srinivasula SM, Wang L, Poyet JL, Geddes BJ, et al. (2002) CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J Biol Chem 277: 13952-13958.
39. Stilo R, Leonardi A, Formisano L, Di Jeso B, Vito P, et al. (2002) TUCAN/ CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation. FEBS Lett 521: 165-169.
40. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, et al. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325.
41. Thome M, Hofmann K, Burns K, Martinon F, Bodmer JL, et al. (1998) Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol 8: 885-888.
42. Martinon F, Hofmann K, Tschopp J (2001) The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol 11: R118-120.
43. Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, et al. (2002) PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 277: 11570-11575.
44. Wang L, Manji GA, Grenier JM, Al-Garawi A, Merriam S, et al. (2002) PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem 277: 29874-29880.
45. Hlaing T, Guo RF, Dilley KA, Loussia JM, Morrish TA, et al. (2001) Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J Biol Chem 276: 9230-9238.
46. Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, et al. (2002) The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med 196: 1605-1615.
47. Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, et al. (2007) The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 14: 1590-1604.
48. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, et al. (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357: 1925-1928.
49. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
50. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, et al. (2001) CARD15 mutations in Blau syndrome. Nat Genet 29: 19-20.
51. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
52. Tanabe T, Chamaillard M, Ogura Y, Zhu L, Qiu S, et al. (2004) Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. Embo J 23: 1587-1597.
53. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, et al. (2007) Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 25: 713-724.
54. Park HH, Lo YC, Lin SC, Wang L, Yang JK, et al. (2007) The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 25: 561-586.
55. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, et al. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517-521.
56. Kinoshita T, Kondoh C, Hasegawa M, Imamura R, Suda T (2006) Fas-associated factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1. Int Immunol 18: 1701-1706.
57. Eckmann L, Karin M (2005) NOD2 and Crohn's disease: loss or gain of function? Immunity 22: 661-667.
58. Gietz RD, Woods RA (2002) Transformation of yeast by lithium acetate/ single-stranded carrier DNA/polyethylene glycol method. Methods Enzymol 350: 87-96.
59. Chu ZL, Pio F, Xie Z, Welsh K, Krajewska M, et al. (2001) A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J Biol Chem 276: 9239-9245.
60. Bertin J, Nir WJ, Fischer CM, Tayber OV, Errada PR, et al. (1999) Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB. J Biol Chem 274: 12955-12958.
61. Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, et al. (2003) ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 303: 69-73.
62. Hu Y, Benedict MA, Wu D, Inohara N, Nunez G (1998) Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A 95: 4386-4391.
63. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489.
64. Riedl SJ, Li W, Chao Y, Schwarzenbacher R, Shi Y (2005) Structure of the apoptotic protease-activating factor 1 bound to ADP. Nature 434: 926-933.
65. Jayapandian M, Chapman A, Tarcea VG, Yu C, Elkiss A, et al. (2007) Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together. Nucleic Acids Res 35: D566-571.
66. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL (2008) GenBank. Nucleic Acids Res 36: D25-30.